Skip to main content

Targeting IRE1 in disease

Objective

The overarching objective of this Interfere to Suppress or Promote IRE1 (INSPIRED) RISE programme is to drive research and innovation in cell stress and drug development for cancer and neurodegenerative diseases by forming an interdisciplinary and intersectoral network of experts with strong, dynamic and productive interactions. The partners will work together, each bringing their unique expertise, to develop new classes of therapeutics for these common diseases. By fostering a shared culture of research, innovation and collaboration, the participants will accelerate advances in the field of cell stress responses. The staff members who participate in the programme will develop new skills, learn new technologies and be exposed to new environments which will considerably enhance their career opportunities. Advancing drug development in the stress response field has potential translational and commercial opportunities for the participants and will benefit European society as a whole from economic and health perspectives.
IRE1 is a stress sensor and signal transducer, activated in response to the accumulation of misfolded proteins in the endoplasmic reticulum (ER). Its activation is part of a process termed the unfolded protein response (UPR) that determines the fate of cells in response to ER stress. The INSPIRED consortium will focus on understanding IRE1 signalling and its role in the stress response in order to target it in specific diseases such as cancers and neurodegenerative disorders where aberrant IRE1 signalling occurs. Research carried out by INSPIRED partners will develop new IRE1 modulators and generate preclinical data to support targeting IRE1 in cancers and neurodegenerative disease.

Call for proposal

H2020-MSCA-RISE-2016
See other projects for this call

Coordinator

NATIONAL UNIVERSITY OF IRELAND GALWAY
Address
University Road
H91 Galway
Ireland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 342 000

Participants (5)

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 135 000
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
ENIOS APPLICATIONS IDIOTIKI KEFALAIOUCHIKI ETAIREIA
Greece
EU contribution
€ 162 000
Address
Al. Pantou 25
17671 Kallithea
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
METASYSX GMBH
Germany
EU contribution
€ 9 000
Address
Am Mühlenberg 11
14476 Potsdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
GOETEBORGS UNIVERSITET
Sweden
EU contribution
€ 27 000
Address
Vasaparken
405 30 Goeteborg
Activity type
Higher or Secondary Education Establishments
CELL STRESS DISCOVERIES LIMITED
Ireland
EU contribution
€ 157 500
Address
Unit 204, Nuig Business Innovation Centre, Newcastle Road
Galway
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (3)

UNIVERSIDAD DE CHILE
Chile
Address
Av. Libertador Bernardo O'higgins 1058
10 Santiago
Activity type
Higher or Secondary Education Establishments
MANNKIND CORPORATION

Participation ended

United States
Address
North Avenue Paine 28903
91355 Valencia
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ORINOVE INC
United States
Address
3537 Old Conejo Road Suite 104
91320 Newbury Park
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)